RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
$5.52
-2.65%
-0.15
Notify me if price changes either direction
Buy RXRX stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
2.4B
Enterprise value
2.0B
Trailing PE
-3.266272178063
Forward PE
-3.1907513
PEG Ratio
-1.3065088712252
Enterprise to EBITDA
-3.346
Enterprise to revenue
30.378
Price to book MRQ
2.59887
Price to sales TTM
37.30491
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-06-30
Revenue (TTM)
64.6M
EBITDA
-586387008
Diluted EPS TTM
-1.81
Total Cash (MRQ)
525.1M
Current ratio (MRQ)
3.58
Operating Cash Flow (TTM)
-383030016
RXRX trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
November 2025
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
